ZURICH (Reuters) – Patients taking Novartis' inhaled medicine Onbrez Breezhaler for chronic lung disease had benefits similar to those taking … Continue reading
The post Novartis lung drug not inferior to GSK’s Seretide, study shows appeared first on Headline News - Scoop Rocket News Headlines.
